Patients diagnosed with hereditary cancer syndromes (HCS) mutations are at increased risk of developing tumors. We are trying to evaluate the utility and cost-effectiveness of WB MRI for screening and monitoring adult HCS patients for new lesions (malignant or pre malignant). We retrospectively collected the data from the HCS patients who had whole-body MRI scans and are aged 18 -72 years old. Overall sensitivity and specificity of WB MRI is 100% and 87.5% and mean per patient cost responsibility per scan is $358.83 which proves WB MRI can be an effective tool for screening and surveillance of HCS patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords